Antibiofilm properties of cathelicidin LL-37: an in-depth review.

Memariani, Hamed et al.·World journal of microbiology & biotechnology·2023·
RPEP-071742023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Antibiofilm properties of cathelicidin LL-37: an in-depth review.
Published In:
World journal of microbiology & biotechnology, 39(4), 99 (2023)
Database ID:
RPEP-07174

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07174·https://rethinkpeptides.com/research/RPEP-07174

APA

Memariani, Hamed; Memariani, Mojtaba. (2023). Antibiofilm properties of cathelicidin LL-37: an in-depth review.. World journal of microbiology & biotechnology, 39(4), 99. https://doi.org/10.1007/s11274-023-03545-z

MLA

Memariani, Hamed, et al. "Antibiofilm properties of cathelicidin LL-37: an in-depth review.." World journal of microbiology & biotechnology, 2023. https://doi.org/10.1007/s11274-023-03545-z

RethinkPeptides

RethinkPeptides Research Database. "Antibiofilm properties of cathelicidin LL-37: an in-depth re..." RPEP-07174. Retrieved from https://rethinkpeptides.com/research/memariani-2023-antibiofilm-properties-of-cathelicidin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.